INVO Fertility (IVF) Net Income Growth (1y) (2012 - 2026)
INVO Fertility (IVF) Net Income Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 125.69% |
| 10 | INVO Fertility | 1.51 Mn | -3.40 Mn | 732,978.00 | 89.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.02% |
| Dec 31, 2025 | 114.46% |
| Sep 30, 2025 | -814.85% |
| Jun 30, 2025 | 75.89% |
| Mar 31, 2025 | -896.63% |
| Dec 31, 2024 | -90.44% |
| Sep 30, 2024 | -30.62% |
| Jun 30, 2024 | -0.21% |
| Mar 31, 2024 | 37.41% |
| Dec 31, 2023 | 28.98% |
| Sep 30, 2023 | 51.03% |
| Jun 30, 2023 | 20.03% |
| Mar 31, 2023 | 13.49% |
| Dec 31, 2022 | -2,818.28% |
| Sep 30, 2022 | -2.75% |
| Jun 30, 2022 | -54.17% |
| Mar 31, 2022 | -20.18% |
| Dec 31, 2021 | 102.67% |
| Sep 30, 2021 | -40.04% |
| Jun 30, 2021 | -37.36% |